QT Imaging Registers 29.3M Shares for Resale Amidst Capital Raises

Ticker: QTIWW · Form: S-1 · Filed: Nov 3, 2025 · CIK: 1844505

Qt Imaging Holdings, Inc. S-1 Filing Summary
FieldDetail
CompanyQt Imaging Holdings, Inc. (QTIWW)
Form TypeS-1
Filed DateNov 3, 2025
Risk Levelhigh
Pages15
Reading Time19 min
Key Dollar Amounts$0.0001, $10,100,000, $5,000,000, $15,100,000, $0.40
Sentimentbearish

Sentiment: bearish

Topics: S-1 Filing, Secondary Offering, Reverse Stock Split, Private Placement, Warrants, Dilution Risk, Medical Imaging

Related Tickers: QTIWW

TL;DR

**QTIWW's S-1 is a red flag for dilution, as insiders are cashing out millions of shares, likely depressing the stock price for retail investors.**

AI Summary

QT Imaging Holdings, Inc. (QTIWW) filed an S-1 on November 3, 2025, to register 29,336,017 shares of common stock for resale by selling securityholders. The company will not receive proceeds from these sales, but will benefit from cash exercises of warrants. Key financial activities include a senior secured term loan with Lynrock Lake Master Fund LP, initially for $10,100,000 on February 26, 2025, and subsequently amended on August 26, 2025, to $15,100,000 at a 10.0% interest rate. The company also completed three private placements in 2025: the First Private Placement on April 9, 2025, raising approximately $500,000; the Second Private Placement on May 12, 2025, raising approximately $200,000; and the Third Private Placement on October 3, 2025, raising approximately $18,180,655. A 3:1 reverse stock split became effective on October 23, 2025, adjusting share counts and warrant exercise prices. The company faces risks from potential market price reduction due to substantial share sales by selling securityholders and the uncertainty of warrant exercises.

Why It Matters

This S-1 filing signals a significant liquidity event for QT Imaging's early investors and lenders, including Lynrock Lake Master Fund LP and company executives, who are now able to resell nearly 30 million shares. While the company won't directly profit from these resales, the potential influx of shares could exert downward pressure on QTIWW's stock price, impacting existing shareholders. The recent $15.1 million loan from Lynrock Lake and over $18.8 million raised through private placements in 2025 highlight the company's ongoing need for capital, suggesting a focus on growth or operational stability in a competitive medical imaging market. Investors should monitor the volume and pricing of these resales closely.

Risk Assessment

Risk Level: high — The filing explicitly states that 'Sales of a substantial number of shares of Common Stock in the public market... could reduce the market price of the Common Stock.' Furthermore, 'Shares of Common Stock held by certain of our stockholders... were purchased at an effective price lower than the current market price... Accordingly, such stockholders could sell their securities at a per-share price that is less than the purchase price other stockholders paid and still realize a significant profit.' This indicates a high risk of downward price pressure and potential dilution for new investors.

Analyst Insight

Investors should exercise extreme caution and consider delaying any new investments in QTIWW until the impact of the selling securityholders' share sales is clearer. Existing shareholders should evaluate their positions given the potential for significant dilution and price volatility as nearly 30 million shares become eligible for resale. Monitor trading volumes and price action closely for signs of heavy selling pressure.

Key Numbers

  • 29,336,017 — Shares of Common Stock (Total shares registered for resale by Selling Securityholders)
  • $15.1M — Senior Secured Term Loan (Increased from $10.1M to $15.1M with Lynrock Lake Master Fund LP at 10.0% interest)
  • 3:1 — Reverse Stock Split Ratio (Became effective on October 23, 2025, adjusting share counts and warrant exercise prices)
  • $18.18M — Third Private Placement Proceeds (Gross proceeds from the October 3, 2025, private placement led by Sio Capital Management, LLC)
  • 24,442,342 — Warrant Shares (Shares issuable upon exercise of Five Year Common Warrants held by Purchasers and Lynrock Lake)
  • $0.40 — Original Lynrock Lake Warrant Exercise Price (Adjusted to $1.20 per share after the 3:1 reverse stock split)
  • 20,333,623 — Adjusted Lynrock Lake Warrant Shares (Number of shares Lynrock Lake can purchase after the 3:1 reverse stock split)
  • $500,000 — First Private Placement Proceeds (Gross proceeds from the April 9, 2025, private placement with Dr. Avi Katz and Dr. Raluca Dinu)
  • $200,000 — Second Private Placement Proceeds (Gross proceeds from the May 12, 2025, private placement with Leon Recanati)
  • 10.0% — Interest Rate (Annual interest rate on the senior secured term loan with Lynrock Lake)

Key Players & Entities

  • QT Imaging Holdings, Inc. (company) — Registrant and issuer of securities
  • Lynrock Lake Master Fund LP (company) — Lender in a $15.1 million senior secured term loan and warrant holder
  • Dr. Raluca Dinu (person) — Chief Executive Officer, Board Member, and First Purchaser in private placement
  • Dr. Avi Katz (person) — Chairman of the Board of Directors and First Purchaser in private placement
  • Leon Recanati (person) — Second Purchaser in private placement
  • Sio Capital Management, LLC (company) — Led the Third Private Placement
  • DLA Piper LLP (US) (company) — Legal counsel for the registrant
  • U.S. Securities and Exchange Commission (regulator) — Regulatory body for the S-1 filing
  • $15,100,000 (dollar_amount) — Aggregate principal amount of the senior secured term loan with Lynrock Lake
  • $18,180,655 (dollar_amount) — Aggregate gross proceeds from the Third Private Placement

FAQ

What is the purpose of QT Imaging Holdings' S-1 filing on November 3, 2025?

The S-1 filing by QT Imaging Holdings, Inc. on November 3, 2025, is to register 29,336,017 shares of common stock for resale by existing selling securityholders. The company will not receive any proceeds from these sales, but may receive proceeds from the cash exercise of associated warrants.

How much capital did QT Imaging Holdings raise through its private placements in 2025?

QT Imaging Holdings completed three private placements in 2025, raising approximately $500,000 from the First Private Placement on April 9, 2025, $200,000 from the Second Private Placement on May 12, 2025, and $18,180,655 from the Third Private Placement on October 3, 2025, totaling approximately $18,880,655 in gross proceeds.

What was the impact of the reverse stock split on QT Imaging Holdings' shares?

QT Imaging Holdings effected a 3:1 reverse stock split on October 23, 2025. This reduced the number of outstanding common shares and adjusted the exercise prices and share counts of warrants, such as the Lynrock Lake Warrant, which saw its exercise price change from $0.40 to $1.20 per share.

Who are the key selling securityholders in QT Imaging Holdings' S-1 filing?

The S-1 filing indicates that the selling securityholders include parties from the private placements, such as Dr. Avi Katz, Dr. Raluca Dinu, Leon Recanati, and investors led by Sio Capital Management, LLC, as well as Lynrock Lake Master Fund LP, which holds a significant warrant.

What are the risks associated with the resale of shares by selling securityholders for QT Imaging Holdings?

The primary risk is that the sale of a substantial number of the 29,336,017 registered shares in the public market could significantly reduce the market price of QT Imaging Holdings' common stock. This could make it difficult for other investors to sell their holdings at favorable prices, especially since many selling securityholders acquired shares at lower effective prices.

What is the status of QT Imaging Holdings' debt financing with Lynrock Lake Master Fund LP?

QT Imaging Holdings entered into a senior secured term loan with Lynrock Lake Master Fund LP for $10,100,000 on February 26, 2025. This was amended on August 26, 2025, to add an additional tranche of $5,000,000, increasing the aggregate principal amount to $15,100,000 at an interest rate of 10.0% per annum.

Will QT Imaging Holdings receive proceeds from the sale of shares by selling securityholders?

No, QT Imaging Holdings will not receive any proceeds from the direct sale of common stock by the selling securityholders. However, the company will receive proceeds if the warrants held by these securityholders are exercised for cash.

What is the trading symbol for QT Imaging Holdings' common stock and public warrants?

QT Imaging Holdings' common stock is traded on the over-the-counter (OTC) Market OTCQB under the symbol "QTIH," and its public warrants are traded on the OTC market under the symbol "QTIWW."

Is QT Imaging Holdings considered an 'emerging growth company'?

Yes, QT Imaging Holdings is an 'emerging growth company' as defined in Section 2(a) of the Securities Act of 1933, as amended, which subjects it to reduced public company reporting requirements.

What is the total number of shares issuable upon the exercise of all warrants mentioned in the S-1 filing?

The S-1 filing indicates that 24,442,342 shares are issuable upon the exercise of Five Year Common Warrants, 523,286 shares upon the exercise of Ten Year Common Warrants, and 1,808,055 shares upon the exercise of Pre-Funded Warrants, totaling 26,773,683 shares issuable upon warrant exercise.

Risk Factors

  • Substantial Resale of Shares [high — market]: The registration of 29,336,017 shares of common stock for resale by selling securityholders poses a significant risk of market price reduction. The substantial volume of shares available for sale could overwhelm demand, leading to downward pressure on the stock price.
  • Warrant Exercise Uncertainty [medium — financial]: The company faces uncertainty regarding the exercise of warrants, which could impact future cash flows and share count. While 24,442,342 warrant shares are issuable, the timing and volume of exercises are not guaranteed, affecting potential dilution and capital infusion.
  • Debt Obligations [high — financial]: The company has a significant senior secured term loan of $15,100,000 with Lynrock Lake Master Fund LP at a 10.0% interest rate. Failure to meet debt obligations could lead to financial distress or default.
  • Reverse Stock Split Impact [medium — market]: The 3:1 reverse stock split effective October 23, 2025, while intended to adjust share counts and exercise prices, could lead to increased volatility or perception issues among investors if not managed effectively.

Industry Context

QT Imaging Holdings, Inc. operates in the medical imaging technology sector. This industry is characterized by rapid technological advancements, significant R&D investment, and a complex regulatory environment. Companies often face competition from established players with substantial resources and a need to demonstrate clinical efficacy and economic value to healthcare providers.

Regulatory Implications

As a medical technology company, QT Imaging is subject to stringent regulations from bodies like the FDA. The S-1 filing itself is a regulatory requirement for public offerings and resales. Compliance with evolving healthcare regulations and data privacy laws (e.g., HIPAA) is critical for market access and operational continuity.

What Investors Should Do

  1. Monitor Selling Shareholder Activity
  2. Assess Warrant Exercise Impact
  3. Analyze Debt Servicing Capacity
  4. Evaluate Post-Reverse Split Performance

Key Dates

  • 2025-11-03: S-1 Filing — Registered 29,336,017 shares for resale by selling securityholders, indicating potential for significant market activity.
  • 2025-10-23: Reverse Stock Split Effective — A 3:1 reverse stock split adjusted share counts and warrant exercise prices, impacting per-share metrics and potentially investor perception.
  • 2025-10-03: Third Private Placement — Raised approximately $18,180,655, providing capital but also potentially increasing the number of outstanding shares or convertible securities.
  • 2025-08-26: Term Loan Amendment — Increased the senior secured term loan with Lynrock Lake Master Fund LP from $10.1M to $15.1M, increasing the company's debt burden and interest expense.
  • 2025-05-12: Second Private Placement — Raised approximately $200,000, contributing to the company's cash position.
  • 2025-04-09: First Private Placement — Raised approximately $500,000, providing initial capital through private equity.
  • 2025-02-26: Senior Secured Term Loan Origination — Secured an initial $10,100,000 loan from Lynrock Lake Master Fund LP, establishing a significant debt obligation.

Glossary

S-1 Filing
A registration statement filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. It provides detailed information about the company's business, financial condition, and the securities being offered. (This filing indicates the company's intent to allow existing shareholders to sell their shares, impacting market supply and potentially the stock price.)
Selling Securityholders
Individuals or entities who own securities and are registering them for resale to the public. The company does not receive proceeds from these sales. (The large number of shares registered by selling securityholders (29,336,017) is a key factor in assessing potential market dilution.)
Warrants
Financial instruments that give the holder the right, but not the obligation, to purchase a company's stock at a specified price (exercise price) within a certain timeframe. (The company has outstanding warrants (24,442,342 shares issuable) which, if exercised, will result in cash proceeds for the company and an increase in outstanding shares.)
Reverse Stock Split
A corporate action where a company reduces the total number of its outstanding shares by consolidating existing shares into fewer, proportionally more valuable shares. This is often done to increase the stock price per share. (The 3:1 reverse stock split effective October 23, 2025, adjusted share counts and warrant exercise prices, impacting per-share valuation and potentially investor perception.)
Senior Secured Term Loan
A type of debt financing that is backed by specific collateral and has priority over other unsecured debts in the event of bankruptcy or liquidation. (The $15.1M loan from Lynrock Lake Master Fund LP at 10.0% interest represents a significant financial obligation and a claim on company assets.)
Private Placement
The sale of securities to a select group of investors, rather than through a public offering. These are typically exempt from SEC registration requirements. (The company conducted three private placements in 2025, raising substantial capital ($500,000, $200,000, and $18,180,655), which impacts its cash position and potentially its ownership structure.)

Year-Over-Year Comparison

This S-1 filing focuses on the resale of shares by existing securityholders and recent financing activities, rather than a comparison to prior periods' financial performance. Key events like the senior secured term loan amendment and multiple private placements indicate significant capital raising and debt incurrence in the current period. The substantial number of shares being registered for resale suggests a potential shift in market dynamics compared to any previous filings that might have focused on initial capital formation or operational updates.

Filing Stats: 4,637 words · 19 min read · ~15 pages · Grade level 17.5 · Accepted 2025-11-03 17:22:01

Key Financial Figures

  • $0.0001 — 7 shares of the common stock, par value $0.0001 per shares (the " Common Stock "), of Q
  • $10,100,000 — ke in the aggregate principal amount of $10,100,000 at an interest rate of 10.0% per annum.
  • $5,000,000 — ment ") to add an additional tranche of $5,000,000 to the loan and increase the aggregate
  • $15,100,000 — rease the aggregate principal amount to $15,100,000. In connection with the Credit Agreemen
  • $0.40 — of Common Stock at an exercise price of $0.40 per share (the " Lynrock Lake Warrant "
  • $1 — ce have been adjusted to 20,333,623 and $1.20, respectively. On April 9, 2025, th
  • $2.16 — e Stock Split have an exercise price of $2.16 per share and are exercisable for an ag
  • $500,000, b — st Private Placement were approximately $500,000, before deducting the placement agent fees
  • $200,000, b — nd Private Placement were approximately $200,000, before deducting the placement agent fees
  • $18,180,655, b — rd Private Placement were approximately $18,180,655, before deducting the placement agent fees

Filing Documents

USE OF PROCEEDS

USE OF PROCEEDS 73 PRIVATE PLACEMENT OF SHARES OF COMMON STOCK AND WARRANTS 74 DIVIDEND POLICY 76 DETERMINATION OF OFFERING PRICE 77 SUMMARY HISTORICAL FINANCIAL INFORMATION OF QT IMAGING 78

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 79

BUSINESS

BUSINESS 100 MANAGEMENT 155

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 167 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 169 OTHER MATERIAL AGREEMENTS 173 PRINCIPAL SECURITYHOLDERS 176 SELLING SECURITYHOLDERS 178 DESCRIPTION OF OUR SECURITIES 180 MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES 190 PLAN OF DISTRIBUTION 196 LEGAL MATTERS 199 EXPERTS 199 WHERE YOU CAN FIND MORE INFORMATION 199 INDEX TO FINANCIAL STATEMENTS F-1

INFORMATION NOT REQUIRED IN PROSPECTUS

PART II INFORMATION NOT REQUIRED IN PROSPECTUS II-1 EXHIBIT INDEX II-7

SIGNATURES

SIGNATURES II-13 i Table of Contents ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the " SEC ") using the "shelf" registration process. Under this shelf registration process, the Selling Securityholders may, from time to time, sell the securities offered by them described in this prospectus. We will not receive any proceeds from the sale by such Selling Securityholder of the securities offered by them described in this prospectus. This prospectus also relates to the issuance by us of the shares of the Common Stock issuable upon the exercise of any Warrants. We will not receive any proceeds from the sale of shares of the Common Stock underlying the Warrants pursuant to this prospectus, except with respect to amounts received by us upon the exercise of the Warrants for cash. The exercise of the Warrants, and any proceeds we may receive from any their exercise, are highly dependent on the price of any our shares of the Common Stock and the spread between the exercise price of the Warrants and the price of our Common Stock at the time of exercise. If the market price of our Common Stock is less the exercise price of a holder's Warrants, it is unlikely that holders will exercise their Warrants. There can be no assurance that our Warrants will be in the money prior to their expiration. Neither we nor the Selling Securityholders have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor the Selling Securityholders take responsibility for, or provide any assurance as to the reliability of, any other information that others may give you. Neither we nor the Selling Securityholders will make an offer to sell these securities in any jurisdiction

View Full Filing

View this S-1 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.